Disclosure 0002146784-26-000004-1

SEC FORM 4

$12,594.96

Keros Therapeutics, Inc. (KROS)

Sale of 1,224 shares at $10.29 per share.

Reporting Person Tanini Annita · Officer Title Corp. Controller & VP, Finance · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0002146784-26-000004 · filed 2026-08-20 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Keros Therapeutics, Inc. (KROS)." Disclosed 2026-08-20. https://desqlong.com/cards/0002146784-26-000004-1 (retrieved 2026-09-26).